BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 27228641)

  • 1. Melatonin for Prevention of Breast Radiation Dermatitis: A Phase II, Prospective, Double-Blind Randomized Trial.
    Ben-David MA; Elkayam R; Gelernter I; Pfeffer RM
    Isr Med Assoc J; 2016; 18(3-4):188-92. PubMed ID: 27228641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A potent steroid cream is superior to emollients in reducing acute radiation dermatitis in breast cancer patients treated with adjuvant radiotherapy. A randomised study of betamethasone versus two moisturizing creams.
    Ulff E; Maroti M; Serup J; Falkmer U
    Radiother Oncol; 2013 Aug; 108(2):287-92. PubMed ID: 23827771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical hyaluronic acid vs. standard of care for the prevention of radiation dermatitis after adjuvant radiotherapy for breast cancer: single-blind randomized phase III clinical trial.
    Pinnix C; Perkins GH; Strom EA; Tereffe W; Woodward W; Oh JL; Arriaga L; Munsell MF; Kelly P; Hoffman KE; Smith BD; Buchholz TA; Yu TK
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):1089-94. PubMed ID: 22172912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multicenter randomized trial of breast intensity-modulated radiation therapy to reduce acute radiation dermatitis.
    Pignol JP; Olivotto I; Rakovitch E; Gardner S; Sixel K; Beckham W; Vu TT; Truong P; Ackerman I; Paszat L
    J Clin Oncol; 2008 May; 26(13):2085-92. PubMed ID: 18285602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of melatonin cream on acute radiation dermatitis in patients with primary breast cancer: A double-blind, randomized, placebo-controlled trial.
    Zetner D; Kamby C; Christophersen C; Gülen S; Paulsen CB; Piga E; Hoffmeyer B; Mahmood F; Rosenberg J
    J Pineal Res; 2023 Aug; 75(1):e12873. PubMed ID: 37055944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective effects of doxepin cream on radiation dermatitis in breast cancer: A single arm double-blind randomized clinical trial.
    Shariati L; Amouheidari A; Naji Esfahani H; Abed A; Haghjooy Javanmard S; Laher I; Ghasemi A; Vaseghi G
    Br J Clin Pharmacol; 2020 Sep; 86(9):1875-1881. PubMed ID: 32040868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute radiation dermatitis and pneumonitis in Japanese breast cancer patients with whole breast hypofractionated radiotherapy compared to conventional radiotherapy.
    Osako T; Oguchi M; Kumada M; Nemoto K; Iwase T; Yamashita T
    Jpn J Clin Oncol; 2008 May; 38(5):334-8. PubMed ID: 18417501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized, double-blind trial on the use of 1% hydrocortisone cream for the prevention of acute radiation dermatitis.
    Meghrajani CF; Co HS; Arcillas JG; Maaño CC; Cupino NA
    Expert Rev Clin Pharmacol; 2016; 9(3):483-91. PubMed ID: 26619355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topical use of phytotherapic cream (Capilen® cream) to prevent radiodermatitis in breast cancer: a prospective historically controlled clinical study.
    Stefanelli A; Forte L; Medoro S; Sgualdo A; Lombardo D; Zini G; Maronta D; Rainieri E; Pascale G; Bagnolatti P; Colella M; Princivalle S; Fiorica F
    G Ital Dermatol Venereol; 2014 Feb; 149(1):107-13. PubMed ID: 24566571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Randomized Trial of Mometasone Furoate 0.1% to Reduce High-Grade Acute Radiation Dermatitis in Breast Cancer Patients Receiving Postmastectomy Radiation.
    Ho AY; Olm-Shipman M; Zhang Z; Siu CT; Wilgucki M; Phung A; Arnold BB; Porinchak M; Lacouture M; McCormick B; Powell SN; Gelblum DY
    Int J Radiat Oncol Biol Phys; 2018 Jun; 101(2):325-333. PubMed ID: 29726361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potent corticosteroid cream (mometasone furoate) significantly reduces acute radiation dermatitis: results from a double-blind, randomized study.
    Boström A; Lindman H; Swartling C; Berne B; Bergh J
    Radiother Oncol; 2001 Jun; 59(3):257-65. PubMed ID: 11369066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized, Prospective, Open-label Phase III Trial Comparing Mebo Ointment With Biafine Cream for the Management of Acute Dermatitis During Radiotherapy for Breast Cancer.
    Geara FB; Eid T; Zouain N; Thebian R; Andraos T; Chehab C; Ramia P; Youssef B; Zeidan YH
    Am J Clin Oncol; 2018 Dec; 41(12):1257-1262. PubMed ID: 29889137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical use of recombinant human epidermal growth factor (EGF)-based cream to prevent radiation dermatitis in breast cancer patients: a single-blind randomized preliminary study.
    Kong M; Hong SE
    Asian Pac J Cancer Prev; 2013; 14(8):4859-64. PubMed ID: 24083759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized, prospective assessment of moisturizer efficacy for the treatment of radiation dermatitis following radiotherapy after breast-conserving surgery.
    Sekiguchi K; Ogita M; Akahane K; Haga C; Ito R; Arai S; Ishida Y; Tsukada Y; Kawamori J
    Jpn J Clin Oncol; 2015 Dec; 45(12):1146-53. PubMed ID: 26491204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nigella sativa L. for prevention of acute radiation dermatitis in breast cancer: A randomized, double-blind, placebo-controlled, clinical trial.
    Rafati M; Ghasemi A; Saeedi M; Habibi E; Salehifar E; Mosazadeh M; Maham M
    Complement Ther Med; 2019 Dec; 47():102205. PubMed ID: 31780017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase II study assessing the effectiveness of Biafine cream as a prophylactic agent for radiation-induced acute skin toxicity to the breast in women undergoing radiotherapy with concomitant CMF chemotherapy.
    Szumacher E; Wighton A; Franssen E; Chow E; Tsao M; Ackerman I; Andersson L; Kim J; Wojcicka A; Ung Y; Sixel K; Hayter C
    Int J Radiat Oncol Biol Phys; 2001 Sep; 51(1):81-6. PubMed ID: 11516855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Double-Blind, Placebo-Controlled Pilot Study of Processed Ultra Emu Oil Versus Placebo in the Prevention of Radiation Dermatitis.
    Rollmann DC; Novotny PJ; Petersen IA; Garces YI; Bauer HJ; Yan ES; Wahner-Roedler D; Vincent A; Sloan JA; Issa Laack NN
    Int J Radiat Oncol Biol Phys; 2015 Jul; 92(3):650-8. PubMed ID: 25936812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between skin phototype and radiation dermatitis in patients with breast cancer treated with breast-conserving therapy: suntan reaction could be a good predictor for radiation pigmentation.
    Yamazaki H; Yoshida K; Nishimura T; Kobayashi K; Tsubokura T; Kodani N; Aibe N; Nishimura T
    J Radiat Res; 2011; 52(4):496-501. PubMed ID: 21905308
    [No Abstract]   [Full Text] [Related]  

  • 19. Topical silymarin administration for prevention of acute radiodermatitis in breast cancer patients: A randomized, double-blind, placebo-controlled clinical trial.
    Karbasforooshan H; Hosseini S; Elyasi S; Fani Pakdel A; Karimi G
    Phytother Res; 2019 Feb; 33(2):379-386. PubMed ID: 30479044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase I study of topical epigallocatechin-3-gallate (EGCG) in patients with breast cancer receiving adjuvant radiotherapy.
    Zhao H; Zhu W; Jia L; Sun X; Chen G; Zhao X; Li X; Meng X; Kong L; Xing L; Yu J
    Br J Radiol; 2016; 89(1058):20150665. PubMed ID: 26607642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.